Table 3.
Assessment of clinical course from initial hematuria presentation to diagnosis with bladder cancer.
| Men | Women | P-value | |
|---|---|---|---|
| Delay in diagnosis of bladder cancer from presentation with hematuria | |||
| Mean no. days from hematuria presentation to bladder cancer diagnosis (95% CI) | 73.6 (71.2–76.1) | 85.4 (81.3–89.4) | <0.001 |
| Median no. days from hematuria presentation to bladder cancer diagnosis (IQR) | 35 (15, 88.5) | 41 (17, 117) | <0.001 |
| Delay < 3 months, n (%) | 4068 (75.1) | 1538 (68.9) | <0.001 |
| Delay 3 to 6 months, n (%) | 583 (10.8) | 308 (13.8) | |
| Delay 6 to 9 months, n (%) | 379 (7.0) | 177 (7.9) | |
| Delay 9 to 12 months, n (%) | 386 (7.1) | 210 (9.4) | |
| Infectious work-up | |||
| Urinalysis sent | 65.8% | 67.8% | 0.11 |
| Mean no. of urinalyses sent (95% CI) | 1.19 (1.16–1.45) | 1.39 (1.16–1.23) | <0.001 |
| Urine culture sent | 38.5% | 49.8% | <0.001 |
| Mean no. of urine cultures sent (95% CI) | 0.53 (0.51–0.55) | 0.83 (0.78–0.88) | <0.001 |
| UTI claim present | 17.6% | 33.1% | <0.001 |
| Any antibiotic filled | 35.4% | 40.1% | <0.001 |
| Malignant work-up | |||
| Any abdominal/pelvic imaging | 77.3% | 73.1% | <0.001 |
| Cytology sent | 36.0% | 39.0% | 0.01 |